CDC34 and precursor B-cell acute lymphoblastic leukemia: CDC34, which is upregulated in B-ALL EVs, is known to facilitate lung cancer progression (84), while NUF2, which is upregulated in the EVs of 6 of 8 B-ALL samples in this study, is known to facilitate the progression of lung adenocarcinoma (85).